Research on precision medicine

Optimization and benefit analysis of precision medical protocol based on consortium

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800015700

Enrollment

Unknown

Registered

2018-04-16

Start date

2018-03-01

Completion date

Unknown

Last updated

2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ten major diseases

Interventions

Precision medical group:Gene detection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. sign up informed consent; 2. aged =18 years old; 3. good compliance; 4. clear diagnosis; 5. patients of low to medium risk; 6. life expectancy =12 weeks; 7. sufficient hematology/liver/kidney function; 8. 7days before research, INR=1.5, PTT or aPTT= 1.5×ULN.

Exclusion criteria

Exclusion criteria: 1. pregnant and breast-feeding women; 2. received other treatments for the current disease; 3. HIV patients; 4. the researchers believe that they are not suitable for this study.

Design outcomes

Primary

Measure	Time frame
Progression free survival;	—

Secondary

Measure	Time frame
Overall Survival;Objective Remission Rate;Health Economics;Adverse Event;	—

Countries

China

Contacts

Public ContactWeimin Li

West China Hospital, Sichuan University

weimi003@yahoo.com+86 028 85423998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026